All Stories

  1. Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions

    Article • Future Oncology, February 2016, Future Medicine

    Dr Camilo Porta

  2. Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis

    Article • Future Oncology, December 2015, Future Medicine

    Dr Matteo Santoni, Dr Camilo Porta

  3. Predicting efficacy of sunitinib in metastatic renal cell carcinoma

    Article • Current Biomarker Findings, May 2014, Taylor & Francis

    Dr Camilo Porta

  4. Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

    Article • ClinicoEconomics and Outcomes Research, January 2011, Taylor & Francis

    Dr Camilo Porta

  5. Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma

    Article • Biologics Targets & Therapy, August 2008, Dove Medical Press

    Dr Camilo Porta